Molecular Cytogenetics Market (2017-2022)

Following a comprehensive research on molecular cytogenetics and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, trends, and opportunities, listed in the market dynamics segment. Increasing focus on preventive healthcare measures, growing genetic abnormalities, increasing aging population and subsequent rise in various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis are the key market drivers covered in the report which will support the industry growth in the forecast period. However, lack of awareness about diagnostic technologies, high cost of diagnosis, unfavorable reimbursement scenario within the molecular cytogenesis, and technical limitations and complexities of the equipment are the major pain points, restraining the adoption of this technology.

The report further gives an extensive outlook on the multifarious verticals/industries served by the molecular cytogenetics techniques. These industries include healthcare, pharmaceutical, biotechnological, and others. The verticals/industry segment further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use molecular cytogenetics techniques in these verticals to improve overall accuracy of disease diagnosis.

An exhaustive analysis of the geographical scenario of the industry for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa are included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market followed by Europe, Asia Pacific, and Rest of World. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2014-2017).

The key players operating in the global molecular cytogenetics market are Thermo Fisher Scientific (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Bio-Rad Laboratories (U.S.), Applied Spectral Imaging (U.S.), Quest Diagnostics (U.S.), Roche Diagnostics (Switzerland) , Danaher Corporation (U.S.), Illumina (U.S.), and Oxford Gene Technology (U.S.).